| Abstrakt: |
New clinical guidelines developed by the University of East Anglia aim to revolutionize the treatment of childhood bone cancer in Europe. The guidelines focus on moving away from untargeted chemotherapy towards precision medicine, with the goal of personalizing treatments and reducing side effects. The framework includes specifications for collecting biological samples from patients, which will help researchers and clinicians understand different subtypes of the disease and develop tailored treatments. The guidelines were developed through collaboration between universities, hospitals, and research institutions across Europe. [Extracted from the article] |
